SoCal Biosciences was born out of a desire to do better. After years of collaborating with
CROs that struggled to meet deadlines, provide accurate data, and fulfill expectations,
founder Dr. Patty Limphong saw an opportunity to utilize her 15+ years in the biotech industry,
including 10+ years of experience in RNA-based therapeutics specifically, and the trust
of her colleagues, to create a CRO that puts quality, reliability, and client collaboration first.
Our mission is to provide dependable, high-quality data through cutting-edge technology and expert assay development, ensuring our clients succeed in advancing their therapeutics. By focusing on efficiency, genuine partnership, and innovation, we’re reshaping the experience of partnering with a bioanalytical CRO.

We consistently meet deadlines with high-quality results, giving you confidence through every phase.
We draw on our extensive expertise to deliver robust, sensitive methods tailored to your unique needs.
We utilize the latest and most suitable instrumentation to deliver precise data for complex studies.
With decades of experience in bioanalysis and expertise in the emerging field of RNA and oligonucleotide drug development, our seasoned team excels in navigating regulatory requirements and scientific challenges.
We work closely with you from start to finish, providing transparency and open communication throughout the process.
Every project is backed by rigorous quality control and managerial review, reflecting our dedication to consistently exceeding expectations.
At SoCal Biosciences, our team of dedicated scientists and experts share a passion for advancing therapeutic research.
